A study published Oct. 12 in the Annals of Internal Medicine that compared three types of direct oral anticoagulants (DOACs) found that rivaroxaban was associated with a much higher risk of overall and major gastrointestinal bleeding than apixaban or dabigatran, according to a study. Other studies yield similar results.The researchers found th...

This WHO Therapeutics and COVID-19: living guideline now includes two recommendations regarding the combination of neutralizing monoclonal antibodies, Casirivimab and Imdevimab: a conditional recommendation in favour of use in non-severe patients (the condition being patients’ risk of severe disease: patients at highest risk represent good candidat...